Skip to content Skip to sidebar Skip to footer

Unlocking Molecular Insight: Digital PCR for Monitoring Chronic Myeloid Leukemia (CML) and Nasopharyngeal Cancer (NPC)

Digital PCR (dPCR) has emerged as a powerful molecular technology that enables highly sensitive and precise nucleic acid quantification through sample partitioning and absolute analysis. Its application in disease monitoring provides enhanced accuracy for detecting low-abundance targets, making it especially valuable in oncology and clinical diagnostics, including Chronic Myeloid Leukemia (CML) and Nasopharyngeal Carcinoma (NPC).

📆 Wednesday, May 20th 2026
🕘 10.00 WIB (GMT+7)
📍 Zoom (link to be announced)

Speakers:

  1. Jing He, Ph.D. – Biological scientist, R&D department, Rainsure Scientific
  2. Ahmad Rusdan Handoyo Utomo, Ph.D. – Lecturer & Researcher at Faculty of Medicine, Yarsi University

Why you should join:

  • Expert-led scientific discussion
  • Latest insights on Digital PCR applications
  • Interactive Q&A session
  • Free e-certificate
  • Networking opportunities with professionals & researchers

Scan the QR code or register yourself in

Register: https://bit.ly/DigitalPCR-Webinar

Our social media

Email: sales@ibs.co.id  
Instagram: https://www.instagram.com/infiniti.ibs/
LinkedIn: https://www.linkedin.com/company/infiniti-ibs

Leave a comment